{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03209986",
      "OrgStudyIdInfo": {
        "OrgStudyId": "XJMSC0001"
      },
      "Organization": {
        "OrgFullName": "Xijing Hospital of Digestive Diseases",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis",
      "OfficialTitle": "Randomized Control Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis Resulted From Viral Hepatitis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2018",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 8, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 30, 2019",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 31, 2019",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 30, 2017",
      "StudyFirstSubmitQCDate": "July 5, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 6, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 10, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 11, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Han Ying",
        "ResponsiblePartyInvestigatorTitle": "Consultant Physician, Professor",
        "ResponsiblePartyInvestigatorAffiliation": "Xijing Hospital of Digestive Diseases"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Xijing Hospital of Digestive Diseases",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "There has been great interest in recent years to take advantage of stem cells to treat liver cirrhosis. Mesenchymal stem cells (MSC) has been shown to be safe and effective for liver diseases in some studies. Randomization controlled studies are needed to confirm the long term effect of MSC treatment for liver cirrhosis. This study aimed to investigate the safety and efficacy of mesenchymal stem cells in hepatitis B and C related liver cirrhosis patients.\n\nThis study is an open-label multicenter randomized control study. Patients with with decompensated cirrhosis will be randomly assigned to receive MSC treatment plus standard medical care(treatment）or standard medical care (control). Three times of MSC infusion (1x10E6 cells/kg body weight) via peripheral vein will be given to the experimental group (once in 4 weeks). The primary outcome is absolute change in liver function indexes and and scores. Secondary outcomes are cirrhosis-related complications, symptoms, life quality, and survival."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Liver Cirrhosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Liver Cirrhosis",
          "Mesenchymal Sem Cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignMaskingDescription": "Outcome assessors will be blind to the randomization results of the participants.",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "200",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSC group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "mesenchymal stem cell transplantation via peripheral vein: 1x10E6 MSCs/kg body weight administered via peripheral vein at week 0, 4, 8.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: mesenchymal stem cell transplantation via peripheral vein",
                "Other: mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "control",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "Standard medication for viral hepatitis and cirrhosis"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "mesenchymal stem cell transplantation via peripheral vein",
            "InterventionDescription": "1x10E6 MSCs/kg body weight will be administered via peripheral vein for 3 times at week 0, 4 and 8",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC group"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "mesenchymal stem cell",
            "InterventionDescription": "mesenchymal stem cell infusion produced by Cell products of National Engineering Research Center(short for CPNERC), Tianjin, China",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Efficacy: Change of liver functions as assessed by MELD score",
            "PrimaryOutcomeDescription": "Change of liver functions as assessed by MELD score (MELD, Model for End-Stage Liver Disease Score: MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43)",
            "PrimaryOutcomeTimeFrame": "1 year"
          },
          {
            "PrimaryOutcomeMeasure": "Safety: Adverse events as assessed according to CTCAE 4.03",
            "PrimaryOutcomeDescription": "Adverse events as assessed according to CTCAE 4.03",
            "PrimaryOutcomeTimeFrame": "1 year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Survival Benefit: Survival Rate at different time points",
            "SecondaryOutcomeDescription": "survival rate at different time points",
            "SecondaryOutcomeTimeFrame": "1 year, 2 year and 5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Histological change of the liver: Histological scores assessed by liver biopsy",
            "SecondaryOutcomeDescription": "histological scores assessed by liver biopsy at baseline and after treatment",
            "SecondaryOutcomeTimeFrame": "1 year, 2 year and 5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical benefit: Incidences of cirrhosis-related complications such as GI bleeding, ascites, hepatorenal syndrome, hepatoencephalopathy",
            "SecondaryOutcomeDescription": "Incidences of cirrhosis-related complications such as GI bleeding, ascites, hepatorenal syndrome, hepatoencephalopathy",
            "SecondaryOutcomeTimeFrame": "1, 2 and 5 years"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAged 18-65 years\nHBV -related liver cirrhosis\nChild-Pugh score ≥7\nWith presentations of decompensation\nWritten consent\n\nExclusion Criteria:\n\nHepatocellular carcinoma or other malignancies\nSevere problems in other vital organs(e.g.the heart,renal or lungs)\nPregnant or lactating women\nSevere bacteria infection\nAnticipated with difficulty of follow-up observation\nCoinfection with HIV or other viral hepatitis.\nDrug abuse or alcohol abuse\nHistory of severe allergy to biological products\nOther candidates who are judged to be not applicable to this study by doctors -",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Changcun Guo, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "862984771539",
            "CentralContactEMail": "guochc@fmmu.edu.cn"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Xijing Hospital of Digestive Disease, Xijing Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Xi'an",
            "LocationState": "Shaanxi",
            "LocationZip": "710032",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Ying Han, Ph.D",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-29-84771539",
                  "LocationContactEMail": "hanying@fmmu.edu.cn"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008103",
            "ConditionMeshTerm": "Liver Cirrhosis"
          },
          {
            "ConditionMeshId": "D000005355",
            "ConditionMeshTerm": "Fibrosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000008107",
            "ConditionAncestorTerm": "Liver Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10255",
            "ConditionBrowseLeafName": "Liver Cirrhosis",
            "ConditionBrowseLeafAsFound": "Liver Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8743",
            "ConditionBrowseLeafName": "Hepatitis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8744",
            "ConditionBrowseLeafName": "Hepatitis A",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafAsFound": "Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10259",
            "ConditionBrowseLeafName": "Liver Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M10262",
            "InterventionBrowseLeafName": "Liver Extracts",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Hemat",
            "InterventionBrowseBranchName": "Hematinics"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}